Overview
A stable, non-explosive inhalation anesthetic, relatively free from significant side effects.
Indication
For induction and maintenance of general anesthesia.
Associated Conditions
No associated conditions information available.
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2025/06/03 | Phase 4 | Not yet recruiting | |||
2024/10/03 | Phase 3 | Recruiting | |||
2024/10/03 | Not Applicable | Completed | |||
2024/05/17 | Phase 2 | Recruiting | |||
2024/03/15 | Not Applicable | Recruiting | University Hospital, Grenoble | ||
2024/02/09 | Not Applicable | Not yet recruiting | |||
2023/08/28 | Phase 2 | Recruiting | |||
2023/08/15 | Early Phase 1 | Recruiting | Our Lady of the Lake Hospital | ||
2023/05/22 | Phase 3 | Recruiting | |||
2023/04/26 | N/A | Not yet recruiting | Hopital of Melun |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| Piramal Critical Care Inc | 66794-011 | RESPIRATORY (INHALATION) | 1 mL in 1 mL | 2/1/2023 | |
| Baxter Healthcare Corporation | 10019-360 | RESPIRATORY (INHALATION) | 1 mL in 1 mL | 4/27/2017 | |
| Piramal Critical Care Inc | 66794-020 | RESPIRATORY (INHALATION) | 1 mL in 1 mL | 2/16/2023 | |
| Piramal Critical Care Inc | 66794-019 | RESPIRATORY (INHALATION) | 1 mL in 1 mL | 2/9/2023 | |
| Halocarbon Life Sciences, LLC | 12164-012 | RESPIRATORY (INHALATION) | 1 mL in 1 mL | 3/27/2020 | |
| Piramal Critical Care, Inc. | 66794-017 | RESPIRATORY (INHALATION) | 1 mL in 1 mL | 1/11/2023 |
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| AERRANE INHALATION ANAESTHETIC | SIN08670P | SOLUTION | 100% | 4/19/1996 | |
| ISOFLURANE INHALATION | SIN07914P | SOLUTION | 100% | 11/15/1994 |
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| Isoflurane | 国药准字H20020267 | 化学药品 | 吸入剂 | 5/20/2020 | |
| Isoflurane | 国药准字HJ20160437 | 化学药品 | 溶液剂 | 9/7/2023 | |
| Isoflurane | 国药准字HJ20160436 | 化学药品 | 溶液剂 | 9/7/2023 | |
| Isoflurane | 国药准字H20249627 | 化学药品 | 吸入制剂 | 12/1/2024 | |
| Isoflurane | 国药准字H20249628 | 化学药品 | 吸入制剂 | 12/1/2024 | |
| Isoflurane | 国药准字H19980141 | 化学药品 | 液体剂 | 4/13/2020 | |
| Isoflurane | 国药准字H19990157 | 化学药品 | 吸入剂 | 2/3/2020 |
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| AERRANE isoflurane 1mL/mL inhalation bottle | 55105 | Medicine | A | 7/17/1996 |
Help Us Improve
Your feedback helps us provide better drug information and insights.